DATE | HS_CODE | Product Description | Trademark | Country | Net Weight | Statistical Cost | Place | Shipper Name | Consignee Name |
---|
2017-09-07 | 2933599500 | Standart pharmacopeia sample (reference sample): norfloxacin CRS system stability ARTICLE Y0001015 (5 vials of 10 mg). CAS 70458-96-7. Chemical name: 1-ETHYL-6-FLUORO-1,4-dihydro-4-oxo-7- (1-piperazinyl) -3-quinolinecarbonyl SM. ADVANCED: OL | *** | FRANCE | 0 | 479,56 | *** | ***** | ***** |
2017-09-25 | 2933399900 | "Clopidogrel system stability" working standards NOT DRUG, POWDER, reference material for examination of active pharmaceutical ingredients, FOR LABORATORY WILL NOT APPLY FOR THE PREVENTION, DIAGNOSIS, TREATMENT | *** | FRANCE | 0 | 198,85 | *** | ***** | ***** |
2017-09-25 | 2933599500 | "Mirtazapine system stability" working standards NOT DRUG, POWDER, reference material for examination of active pharmaceutical ingredients, FOR LABORATORY WILL NOT APPLY FOR THE PREVENTION, DIAGNOSIS, TREATMENT | *** | FRANCE | 0 | 198,85 | *** | ***** | ***** |
2017-10-01 | 2933299000 | "Losartan system stability" working standards NOT DRUG, POWDER, STANDARD MODEL FOR EXAMINATION PROVEDENIYA active pharmaceutical ingredients, LABORATORNYH__1.0__ TO BE APPLIED FOR THE PREVENTION, DIAGNOSIS, LE | ABSENT | FRANCE | 1E-06 | 566,3 | MOSCOW | ***** | ***** |
2017-10-23 | 2933299000 | "Losartan system stability" working standards NOT DRUG, POWDER, reference material for examination of active pharmaceutical ingredients, LABORATORNYH__1.0__ TO BE APPLIED FOR THE PREVENTION, DIAGNOSIS, LE | ABSENT | FRANCE | 1E-06 | 566,18 | MOSCOW | ***** | ***** |
2017-11-12 | 2933599500 | "Mirtazapine system stability" working standards NOT DRUG, POWDER, reference material for examination of active pharmaceutical ingredients, FOR LABORATORY | ABSENT | FRANCE | 1E-05 | 97,3 | MOSCOW | ***** | ***** |